Medline (MDLN) 10% Owner Mozart Holdco Exchanges 500,000 Units
$MDLN · Medline Inc.Research Summary
AI-generated summary of this SEC filing
Medline (MDLN) 10% Owner Mozart Holdco Exchanges 500,000 Units
What Happened Mozart Holdco, Inc., reported as a 10% owner of Medline (MDLN), completed non‑cash exchanges on August 6, 2026. The Form 4 shows: an acquisition of 500,000 shares via conversion of a derivative security (priced at $0.00), and the disposition/cancellation of 500,000 Class B shares (and a related derivative disposition of 500,000). These transactions reflect an exchange of common units for an equal number of Class A common shares under an Exchange Agreement — no cash changed hands (all reported at $0.00).
Key Details
- Transaction date: 2026-08-06; Form 4 filed 2026-08-07.
- Reported transactions: +500,000 Class A shares via conversion (code C, $0.00); disposal/cancellation of 500,000 Class B shares (codes J and C, $0.00).
- Total cash value reported: $0 (these were unit-for-stock exchanges, not market purchases/sales).
- Footnotes: F1–F3 explain the exchange agreement (dated Dec 16, 2025), the cancellation of equal numbers of Class B shares upon exchange, that Class B shares have no economic value and carry one vote, and that exchange rights are one‑for‑one and do not expire. Transactions are exempt from Section 16(b) relying on Rule 16b‑6(b).
- Shares owned after the transaction: not specified in the provided summary of the filing.
- Filing timeliness: Form 4 was filed the day after the transactions (within the normal 2‑business‑day window for Section 16 insiders).
Context This was a structural conversion of common units into Class A common stock by a 10% holder (institutional/ownership reclassification), not a cash buy or sell on the open market. For retail investors: such exchanges are administrative and reflect ownership class conversion and cancellation of Class B shares; they are not direct indicators of the holder buying or selling for cash or changing market sentiment.